SCHEMBL3570981

SCHEMBL3570981

CCCCC1(C(N)Cc2ccccc2)CCC2(CC1)OCCO2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1E P49674 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 1/20 0.36
ALDH1A1 P00352 2/20 0.36
TSHR P16473 1/20 0.36
SLC6A2 P23975 2/20 0.35
TAAR1 Q96RJ0 2/20 0.35
MAOA P21397 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
CYP2A6 P11509 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
ANPEP P15144 1/20 0.34
LAP3 P28838 1/20 0.34
DAGLA Q9Y4D2 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3566908 0.79
SCHEMBL3218466 0.70 MAOA (0.35) L3MBTL1MEN1KMT2AGAAALDH1A1
SCHEMBL3570982 0.69 OPRM1 (0.37) MEN1KMT2AALDH1A1MAOASIGMAR1
SCHEMBL14778575 0.68 MMP2 (0.42) L3MBTL1MEN1KMT2AGAAMAOA
SCHEMBL3573052 0.68 ALDH1A1 (0.39) L3MBTL1MEN1KMT2AGAAALDH1A1
SCHEMBL4876798 0.67 MEN1 (0.41) L3MBTL1MEN1KMT2AALDH1A1TSHR
SCHEMBL3573053 0.67 SLC6A4 (0.33) L3MBTL1MEN1KMT2AALDH1A1TSHR
SCHEMBL12346167 0.67 MAOA (0.41) L3MBTL1MEN1KMT2AGAAALDH1A1
SCHEMBL4289424 0.66 POLB (0.43) L3MBTL1KMT2AGAAALDH1A1TSHR
SCHEMBL2108433 0.65 EPHX1 (0.44) SLC6A2TAAR1MAOASLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121689-B1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2013-07-31 EP disclosed
US-8404740-B2 Spirocyclic cyclohexane compounds GRUENENTHAL GMBH (DE) 2013-03-26 US disclosed
US-20100048554-A1 Spirocyclic Cyclohexane Compounds GRUENENTHAL GMBH (DE) 2010-02-25 US disclosed
EP-2121689-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2009-11-25 EP disclosed
WO-2008101659-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2008-08-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048554-A1 Spirocyclic Cyclohexane Compounds OPRL1, OPRD1, OPRK1 CSNK1E 995/4885L3MBTL1 1622/4885MEN1 3242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.